Zhilin Sui

Chinese Academy Of Medical Sciences And Peking Union Medical College
Shenzhen, 518116, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Nomogram for predicting pathological complete response to neoadjuvant chemoimmunotherapy in patients with resectable non-small cell lung cancer.

Nomogram for predicting pathological complete response to neoadjuvant chemoimmunotherapy in patients with resectable non-small cell lung cancer.

Journal: Frontiers in cell and developmental biology

Published: August 05, 2025

Pembrolizumab treatment in SMARCA4-deficient nonsmall cell lung cancer: high tumor mutational burden and programmed death-ligand 1(+) expression on circulating tumor cells for real-time monitoring: a case report.

Pembrolizumab treatment in SMARCA4-deficient nonsmall cell lung cancer: high tumor mutational burden and programmed death-ligand 1(+) expression on circulating tumor cells for real-time monitoring: a case report.

Journal: Anti-cancer drugs

Published: June 22, 2025

Exploring a mutation-based signature to predict the benefits of immune checkpoint inhibitors in oncogene-addicted subsets of non-small cell lung cancer: a retrospective study.

Exploring a mutation-based signature to predict the benefits of immune checkpoint inhibitors in oncogene-addicted subsets of non-small cell lung cancer: a retrospective study.

Journal: Respiratory research

Published: June 08, 2025

Targeted tumor cell-intrinsic CTRP6 biomimetic codelivery synergistically amplifies ferroptosis and immune activation to boost anti-PD-L1 immunotherapy efficacy in lung cancer.

Targeted tumor cell-intrinsic CTRP6 biomimetic codelivery synergistically amplifies ferroptosis and immune activation to boost anti-PD-L1 immunotherapy efficacy in lung cancer.

Journal: Journal of nanobiotechnology

Published: February 17, 2025

Multi-omics sequencing of gastroesophageal junction adenocarcinoma reveals prognosis-relevant key factors and a novel immunogenomic classification.

Multi-omics sequencing of gastroesophageal junction adenocarcinoma reveals prognosis-relevant key factors and a novel immunogenomic classification.

Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association

Published: September 06, 2024

Mesenchymal stromal cells promote the formation of lung cancer organoids via Kindlin-2.

Mesenchymal stromal cells promote the formation of lung cancer organoids via Kindlin-2.

Journal: Stem cell research & therapy

Published: August 26, 2024

Biomimetic hydrogels with mesoscale collagen architecture for patient-derived tumor organoids culture.

Biomimetic hydrogels with mesoscale collagen architecture for patient-derived tumor organoids culture.

Journal: Bioactive materials

Published: December 05, 2023

Development and validation of web-based dynamic nomograms predictive of disease-free and overall survival in patients who underwent pneumonectomy for primary lung cancer.

Development and validation of web-based dynamic nomograms predictive of disease-free and overall survival in patients who underwent pneumonectomy for primary lung cancer.

Journal: PeerJ

Published: May 25, 2023

USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1.

USP4 promotes the proliferation, migration, and invasion of esophageal squamous cell carcinoma by targeting TAK1.

Journal: Cell death & disease

Published: February 13, 2023

Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma.

Establishment of a risk model by integrating hypoxia genes in predicting prognosis of esophageal squamous cell carcinoma.

Journal: Cancer medicine

Published: March 07, 2022

Characterization of the Immune Cell Infiltration Landscape in Esophageal Squamous Cell Carcinoma.

Characterization of the Immune Cell Infiltration Landscape in Esophageal Squamous Cell Carcinoma.

Journal: Frontiers in oncology

Published: February 19, 2022

CXCR4 promotes the growth and metastasis of esophageal squamous cell carcinoma as a critical downstream mediator of HIF-1α.

CXCR4 promotes the growth and metastasis of esophageal squamous cell carcinoma as a critical downstream mediator of HIF-1α.

Journal: Cancer science

Published: July 23, 2021

Showing 1-12 of 18

Last Updated: 09/26/2026